UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000021369
Receipt number R000024644
Scientific Title Study on safety and efficacy of the whole brain radiation 20Gy/5 time for the metastatic brain tumor
Date of disclosure of the study information 2016/03/07
Last modified on 2018/04/07 00:11:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on safety and efficacy of the whole brain radiation 20Gy/5 time for the metastatic brain tumor

Acronym

Study on safety and efficacy of the whole brain radiation 20Gy/5 time

Scientific Title

Study on safety and efficacy of the whole brain radiation 20Gy/5 time for the metastatic brain tumor

Scientific Title:Acronym

Study on safety and efficacy of the whole brain radiation 20Gy/5 time

Region

Japan


Condition

Condition

metastatic brain tumor

Classification by specialty

Hematology and clinical oncology Neurology Radiology
Neurosurgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Safe evaluation of the whole brain radiation 20Gy/5 time

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Having onset of harmful phenomenon or not

Key secondary outcomes

Reduction effect of tumor
All survival periods


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

It enforces whole brain radiation at 4 Gy once a day for five days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) The existence of the metastatic brain tumor was confirmed by CT or MRI
2) Primary tumor or having a diagnosis of an epithelial tumor (squamous cell carcinoma, adenocarcinoma) pathologically in a metastatic site
3) A vital prognosis is predicted in KPS<70 with 2-3 months
4) Age at the time of the agreement acquisition being more than 20 years old
5) An agreement being provided in a document from the patient about the trial entry

Key exclusion criteria

1) There is a history of the radiotherapy to the head
2) It was taken as the adaptation of localization radiotherapy and the surgical remedy
3) The patient whom physique maintenance is not possible, and radiotherapy cannot enforce
4) Woman with the likelihood of during the pregnancy or the pregnancy
5) The patient who judged it to be inadequate by the judgment of the examination medical attendant

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akifumi Niiya

Organization

Showa University Hospital

Division name

Radiotherapy department

Zip code


Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8570

Email

cual6_po4_4_oh_8_4h2o@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akifumi Niiya

Organization

Showa University Hospital

Division name

Radiotherapy department

Zip code


Address

1-5-8, Hatanodai, Shinagawa-ku, Tokyo

TEL

03-3784-8570

Homepage URL


Email

cual6_po4_4_oh_8_4h2o@yahoo.co.jp


Sponsor or person

Institute

Showa University Hospital radiotherapy department

Institute

Department

Personal name



Funding Source

Organization

Showa University Hospital radiotherapy department

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Juntendo University Urayasu Hospital radiology department

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学病院(東京都)、順天堂大学医学部附属浦安病院(千葉県)


Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 01 Month 07 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 07 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 03 Month 07 Day

Last modified on

2018 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024644


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name